Véronique Lisi

Véronique Lisi

Auto-generated profile, based on publicly available information

Véronique Lisi

Centre de recherche Azrieli du CHU Sainte-Justine, Montréal, QC, Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2012 in RNA
Verified
Journal Article
Open access
PDF file
JCJosé Almeida Cruz
José Almeida Cruz
MBMarc-Frédérick Blanchet
Marc-Frédérick Blanchet
MBMichal Boniecki
Michal Boniecki
JBJanusz M. Bujnicki
Janusz M. Bujnicki
SCShi-Jie Chen
Shi-Jie Chen
EWEric Westhof
Eric Westhof
We report the results of a first, collective, blind experiment in RNA three-dimensional (3D) structure prediction, encompassing three prediction puzzles. The goals are to assess the leading edge of RNA structure prediction techniques; compare existing methods and tools; and evaluate their relative strengths, weaknesses, and limitations in terms of sequence length and structural complexity. The results should give potential users insight into the suitability of available methods for different applications and facilitate efforts in the RNA structure prediction community in ongoing efforts to improve prediction tools. We also report the creation of an automated evaluation pipeline to facilitate the analysis of future RNA structure prediction exercises.

30 November 2020 in Cell
Verified
Journal Article
Closed access
CCCarol C.L. Chen
Carol C.L. Chen
SDShriya Deshmukh
Shriya Deshmukh
SJSelin Jessa
Selin Jessa
DHDjihad Hadjadj
Djihad Hadjadj
VLVéronique Lisi
Véronique Lisi
NJNada Jabado
Nada Jabado

1 June 2016 in Neuron
Verified
Journal Article
Closed access
NRNeha Rani
Neha Rani
TNTomasz J. Nowakowski
Tomasz J. Nowakowski
HZHongjun Zhou
Hongjun Zhou
SGSirie E. Godshalk
Sirie E. Godshalk
VLVéronique Lisi
Véronique Lisi
KKKenneth S. Kosik
Kenneth S. Kosik

1 December 2020 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
SKSima Khazaei
Sima Khazaei
NJNicolas De Jay
Nicolas De Jay
SDShriya Deshmukh
Shriya Deshmukh
LHLiam Hendrikse
Liam Hendrikse
WJWajih Jawhar
Wajih Jawhar
NJNada Jabado
Nada Jabado
Glycine 34-to-tryptophan (G34W) substitutions in H3.3 arise in approximately 90% of giant cell tumor of bone (GCT). Here, we show H3.3 G34W is necessary for tumor formation. By profiling the epigenome, transcriptome, and secreted proteome of patient samples and tumor-derived cells CRISPR–Cas9-edited for H3.3 G34W, we show that H3.3K36me3 loss on mutant H3.3 alters the deposition of the repressive H3K27me3 mark from intergenic to genic regions, beyond areas of H3.3 deposition. This promotes redistribution of other chromatin marks and aberrant transcription, altering cell fate in mesenchymal progenitors and hindering differentiation. Single-cell transcriptomics reveals that H3.3 G34W stromal cells recapitulate a neoplastic trajectory from a SPP1+ osteoblast-like progenitor population toward an ACTA2+ myofibroblast-like population, which secretes extracellular matrix ligands predicted to recruit and activate osteoclasts. Our findings suggest that H3.3 G34W leads to GCT by sustaining a transformed state in osteoblast-like progenitors, which promotes neoplastic growth, pathologic recruitment of giant osteoclasts, and bone destruction. Significance: This study shows that H3.3 G34W drives GCT tumorigenesis through aberrant epigenetic remodeling, altering differentiation trajectories in mesenchymal progenitors. H3.3 G34W promotes in neoplastic stromal cells an osteoblast-like progenitor state that enables undue interactions with the tumor microenvironment, driving GCT pathogenesis. These epigenetic changes may be amenable to therapeutic targeting in GCT. See related commentary by Licht, p. 1794. This article is highlighted in the In This Issue feature, p. 1775

19 January 2023 in Blood
Verified
Journal Article
Closed access
PDF file
ECEdouard Charlebois
Edouard Charlebois
CFCarine Christelle Fillebeen
Carine Christelle Fillebeen
JPJohn F Presley
John F Presley
GCGaël Cagnone
Gaël Cagnone
VLVéronique Lisi
Véronique Lisi
Kostas PantopoulosKostas Pantopoulos
Kostas Pantopoulos
Homeostatic adaptation to systemic iron overload involves transcriptional induction of bone morphogenetic protein 6 (BMP6) in liver sinusoidal endothelial cells (LSECs). BMP6 is then secreted to activate signaling of the iron hormone hepcidin (HAMP) in neighboring hepatocytes. To explore the mechanism of iron sensing by LSECs, we generated TfrcTek-Cre mice with endothelial cell–specific ablation of transferrin receptor 1 (Tfr1). We also used control Tfrcfl/fl mice to characterize the LSEC-specific molecular responses to iron using single-cell transcriptomics. TfrcTek-Cre animals tended to have modestly increased liver iron content (LIC) compared with Tfrcfl/fl controls but expressed physiological Bmp6 and Hamp messenger RNA (mRNA). Despite a transient inability to upregulate Bmp6, they eventually respond to iron challenges with Bmp6 and Hamp induction, yet occasionally to levels slightly lower relative to LIC. High dietary iron intake triggered the accumulation of serum nontransferrin bound iron (NTBI), which significantly correlated with liver Bmp6 and Hamp mRNA levels and elicited more profound alterations in the LSEC transcriptome than holo-transferrin injection. This culminated in the robust induction of Bmp6 and other nuclear factor erythroid 2–related factor 2 (Nrf2) target genes, as well as Myc target genes involved in ribosomal biogenesis and protein synthesis. LSECs and midzonal hepatocytes were the most responsive liver cells to iron challenges and exhibited the highest expression of Bmp6 and Hamp mRNAs, respectively. Our data suggest that during systemic iron overload, LSECs internalize NTBI, which promotes oxidative stress and thereby transcriptionally induces Bmp6 via Nrf2. Tfr1 appears to contribute to iron sensing by LSECs, mostly under low iron conditions.

1 August 2017 in Cell Reports
Verified
Journal Article
Open access
VLVéronique Lisi
Véronique Lisi
BSBhagat Singh
Bhagat Singh
MGMichel Giroux
Michel Giroux
EGElmer Guzman
Elmer Guzman
MPMichio W. Painter
Michio W. Painter
KKKenneth S. Kosik
Kenneth S. Kosik
Peripheral nerve regeneration after injury requires a broad program of transcriptional changes. We investigated the basis for the enhanced nerve regenerative capacity of the CAST/Ei mouse strain relative to C57BL/6 mice. RNA sequencing of dorsal root ganglia (DRG) showed a CAST/Ei-specific upregulation of Ascl1 after injury. Ascl1 overexpression in DRG neurons of C57BL/6 mice enhanced their neurite outgrowth. Ascl1 is regulated by miR-7048-3p, which is downregulated in CAST/Ei mice. Inhibition of miR-7048-3p enhances neurite outgrowth. Following injury, CAST/Ei neurons largely retained their mature neuronal profile as determined by single-cell RNA- seq, whereas the C57BL/6 neurons acquired an immature profile. These findings suggest that one facet of the enhanced regenerative phenotype is preservation of neuronal identity in response to injury.